OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Oncolytic herpes simplex viruses for the treatment of glioma and targeting glioblastoma stem-like cells
Kimia Kardani, Judit Sánchez Gil, Samuel D. Rabkin
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 14
Kimia Kardani, Judit Sánchez Gil, Samuel D. Rabkin
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 14
Showing 14 citing articles:
Oncolytic herpes simplex virus expressing IL-2 controls glioblastoma growth and improves survival
Praveen K. Bommareddy, Hiroaki Wakimoto, Robert L. Martuza, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e008880-e008880
Open Access | Times Cited: 13
Praveen K. Bommareddy, Hiroaki Wakimoto, Robert L. Martuza, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e008880-e008880
Open Access | Times Cited: 13
Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives
Jiyuan Liu, Fan Yang, Jinqu Hu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 11
Jiyuan Liu, Fan Yang, Jinqu Hu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 11
Safety of non-replicative and oncolytic replication-selective HSV vectors
Alberto L. Epstein, Samuel D. Rabkin
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 781-794
Open Access | Times Cited: 6
Alberto L. Epstein, Samuel D. Rabkin
Trends in Molecular Medicine (2024) Vol. 30, Iss. 8, pp. 781-794
Open Access | Times Cited: 6
Repurposing of Zika virus live-attenuated vaccine (ZIKV-LAV) strains as oncolytic viruses targeting human glioblastoma multiforme cells
Carla Bianca Luena Victorio, Wisna Novera, Arun Ganasarajah, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Carla Bianca Luena Victorio, Wisna Novera, Arun Ganasarajah, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Unmasking the potential: mechanisms of neuroinflammatory modulation by oncolytic viruses in glioblastoma
Narimene Beder, Seyedeh Nasim Mirbahari, Mourad Belkhelfa, et al.
Exploration of Targeted Anti-tumor Therapy (2025)
Open Access
Narimene Beder, Seyedeh Nasim Mirbahari, Mourad Belkhelfa, et al.
Exploration of Targeted Anti-tumor Therapy (2025)
Open Access
Novel strategy to target glioblastoma-initiating cells using a braintropic adeno-associated virus carrying a miR-dependent genome-editing system
Zhe Wang, Peijian Zou, Zhenzhong Chen, et al.
British Journal of Cancer (2025)
Closed Access
Zhe Wang, Peijian Zou, Zhenzhong Chen, et al.
British Journal of Cancer (2025)
Closed Access
Advances in oncolytic herpes simplex virus and adenovirus therapy for recurrent glioma
Ming‐Ming Hu, XuLiang Liao, Tao Yi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Ming‐Ming Hu, XuLiang Liao, Tao Yi, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Combination of Oncolytic Virotherapy with Different Antitumor Approaches against Glioblastoma
Alisa B. Ageenko, Natalia S. Vasileva, Vladimir A. Richter, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2042-2042
Open Access | Times Cited: 2
Alisa B. Ageenko, Natalia S. Vasileva, Vladimir A. Richter, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2042-2042
Open Access | Times Cited: 2
Noninvasive therapy of brain cancer using a unique systemic delivery methodology with a cancer terminator virus
Praveen Bhoopathi, Padmanabhan Mannangatti, Anjan K. Pradhan, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 8
Closed Access | Times Cited: 1
Praveen Bhoopathi, Padmanabhan Mannangatti, Anjan K. Pradhan, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 8
Closed Access | Times Cited: 1
Mathematical Modelling of Reoviruses in Cancer Cell Cultures
Arwa Abdulla Baabdulla, Francisca Cristi, Maya Shmulevitz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
Arwa Abdulla Baabdulla, Francisca Cristi, Maya Shmulevitz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Closed Access
The potential of gene delivery for the treatment of traumatic brain injury
James Dooley, Jasmine G. Hughes, Edward Needham, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access
James Dooley, Jasmine G. Hughes, Edward Needham, et al.
Journal of Neuroinflammation (2024) Vol. 21, Iss. 1
Open Access
Cancer Immunotherapies Targeting Cancer Stem Cells: Concepts, Applications, and Advances
Pooya Farhangnia, Mohammad-Reza Shokri, Mahzad Akbarpour, et al.
Interdisciplinary cancer research (2024)
Closed Access
Pooya Farhangnia, Mohammad-Reza Shokri, Mahzad Akbarpour, et al.
Interdisciplinary cancer research (2024)
Closed Access
Developing a novel therapeutic strategy against cancer stem cell heterogeneity and plasticity
Tôru Kondo
(2024), pp. 1-19
Open Access
Tôru Kondo
(2024), pp. 1-19
Open Access
immunocompetent murine glioblastoma stem-like cell models exhibiting distinct phenotypes
Kimia Kardani, Shanawaz M. Ghouse, Muzammil Arif Din Abdul Jabbar, et al.
Neuro-Oncology Advances (2024) Vol. 7, Iss. 1
Open Access
Kimia Kardani, Shanawaz M. Ghouse, Muzammil Arif Din Abdul Jabbar, et al.
Neuro-Oncology Advances (2024) Vol. 7, Iss. 1
Open Access
